Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Jeff Craven

News

Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD

Author:
Jeff Craven
Publish date: July 11, 2022

Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.

  • Read More

News

Therapeutic patient education can help with adherence to treatment

Author:
Jeff Craven
Publish date: June 9, 2022

Therapeutic patient education is recommended for children and adults with moderate to severe AD in the 2020 European Task Force on Atopic...

  • Read More

News

Steroid phobia drives weaker prescribing, nonadherence for AD

Author:
Jeff Craven
Publish date: May 9, 2022

The source of these fears can be information from friends, relatives, media, the Internet, as well as doctors.

  • Read More

News

Repurposed drug could revolutionize stem cell transplantation

Author:
Jeff Craven
Publish date: March 18, 2022

Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...

  • Read More

News

Early treatment may delay atherosclerosis in familial hypercholesterolemia

Author:
Jeff Craven
Publish date: March 7, 2022

Cholesterol-lowering treatment early in life appeared to slow intima-media growth in a meta-analysis.

  • Read More

News

Health disparities exist all over rheumatology: What can be done?

Author:
Jeff Craven
Publish date: February 28, 2022

Health equity should be a “desirable goal” for patients who experience health disparities, but it needs to be a “continuous effort,” said Dr....

  • Read More

News

Rheumatology patients seek guidance on CBD, cannabis products

Author:
Jeff Craven
Publish date: February 25, 2022

Dr. Orrin Troum suggests putting away any personal biases you may have to learn how to best advise patients who are using or considering using...

  • Read More

News

Treat-to-target in RA: Questions remain about adoption, measurement

Author:
Jeff Craven
Publish date: February 22, 2022

Rheumatologists Jack Cush and Martin Bergman debate the value of using a treat-to-target approach in managing patients with RA, focusing on...

  • Read More

News

Patients are interrupting DMARD use well into the COVID-19 pandemic

Author:
Jeff Craven
Publish date: February 17, 2022

Rates of patients stopping disease-modifying antirheumatic drugs (DMARDs) have begun to rise after initially falling during the pandemic, with...

  • Read More

News

Eighteen-year study shows inconsistencies in treating, classifying JIA

Author:
Jeff Craven
Publish date: February 15, 2022

A long-term study of children with juvenile idiopathic arthritis highlights an inconsistent classification system and hints about how they manage...

  • Read More

News

Universal hepatitis B screening, vaccination deemed cost effective for pregnant women

Author:
Jeff Craven
Publish date: February 10, 2022

Clinicians may be more aware of the need to add hepatitis B screening to prenatal care given that routine hepatitis C screening for pregnant women...

  • Read More

News

Researchers identify growing racial disparity in endometrial cancer mortality

Author:
Jeff Craven
Publish date: February 10, 2022

The 5-year relative survival rate for Black women is 63%, compared with 84% for White women – a 21% gap in absolute terms.

  • Read More

News

Close-up of bottles of COVID-19 vaccine

Rituximab and COVID-19 vaccines: Studies begin to answer key questions

Author:
Jeff Craven
Publish date: January 21, 2022

This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...

  • Read More

News

Duloxetine added to usual care doesn’t improve hip, knee OA pain

Author:
Jeff Craven
Publish date: January 6, 2022

The results of a small, randomized trial conducted in general practitioner practices could not find any benefit of duloxetine over usual care in...

  • Read More

News

Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasis

Author:
Jeff Craven
Publish date: January 4, 2022

“These case series confirm the rarity of both generalized pustular psoriasis and palmoplantar pustulosis ... and the lack of effective treatment...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close